Spondylarthritis in the absence of B lymphocytes

Arthritis and Rheumatism

Volumn 58, Issue 3, 2008, Pages 730-733

  Baeten, Dominique ^a   Kruithof, Elli ^b   Breban, Maxime ^c   Tak, Paul P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETANERCEPT; HLA B27 ANTIGEN; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RITUXIMAB; SALAZOSULFAPYRIDINE; VINCRISTINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; B LYMPHOCYTE; CASE REPORT; DISEASE ACTIVITY; FOLLOW UP; HUMAN; LYMPHOCYTE DEPLETION; MALE; NONHODGKIN LYMPHOMA; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SACROILIITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; SPONDYLARTHRITIS;

EID: 40549096018     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23266     Document Type: Article

References (19)

1. Van Denderen JC, Van der Paardt M, Nurmohamed MT, De Ryck YM, Dijkmans BA, Van der Horst-Bruinsma IE. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis. Ann Rheum Dis 2005;64:1761-4.
2. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81.
3. Baeten D, Demetter P, Cuvelier C, Van den Bosch F, Kruithof E, Van Damme N, et al. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthopathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 2000;59:945-53.
4. Appel H, Kuhne M, Spiekermann S, Ebhardt H, Grozdanovic Z, Kohler D, et al. Immunhistologic analysis of zygoapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006;54:2845-51.
5. Schroder AE, Sieper J, Berek C. Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis. Mol Med 1997;3:260-72.
6. Kruithof E, Baeten D, Van den Bosch F, Mielants H, Veys EM, De Keyser F. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy. Ann Rheum Dis 2005;64:529-36.
7. Kruithof E, De Rycke L, Roth J, Mielants H, Van den Bosch F, De Keyser F, et al. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. Arthritis Rheum 2005;52:3898-909.
8. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
9. Shi S, Ciurli C, Cartman A, Pidoux I, Poole AR, Zhang Y. Experimental immunity to the G1 domain of the proteoglycan versican induces spondylitis and sacroiliitis, of a kind seen in human spondylarthropathies. Arthritis Rheum 2003;48:2903-15.
10. Zhang Y, Guerassimov A, Leroux JY, Cartman A, Webber C, Lalic R, et al. Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998;153:1283-91.
11. O'Neill SK, Shlomchik MJ, Giant TT, Cao Y, Doodes PD, Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 2005;174:3781-8.
12. Hertzberger-ten Cate R, Vossen JM, Dijkmans BA. Juvenile ankylosing spondylitis in X-linked agammaglobulinaemia. Br J Rheumatol 1993;32:938-9.
13. Palazzi C, D'Amico E, Cacciatore P, Pennese E, Petricca A, Olivieri I. Juvenile onset psoriatic arthritis: a patient with X-linked agammaglobulinemia (Bruton's disease). Scand J Rheumatol 2003;32:309-11.
14. Good RA, Rotstein J. Rheumatoid arthritis and agammaglobulinemia. Bull Rheum Dis 1960;70:203-6.
15. Hermaszewski R, Ratnavel R, Webster AD, Denman AM. Rheumatoid arthritis in a patient with primary hypogammaglobulinae-mia. Br J Rheumatol 1993;32:636-9.
16. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006;176:705-10.
17. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007. E-pub ahead of print.
18. Dass S, Vital EM, Emery P. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum 2007;56:2715-8.
19. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.